Pediatric Yellow Fever Differential Diagnoses
- Author: David J Cennimo, MD, FACP, FAAP, AAHIVS; Chief Editor: Russell W Steele, MD more...
Diagnostic Considerations
In addition to the conditions listed in the differential diagnosis, other problems to be considered include the following:
- Arboviral infections - Lassa fever, chikungunya, dengue
- Carbon tetrachloride poisoning
- Influenza
- Hepatitis E
- Sepsis
- Typhoid fever
- West Nile virus infection (with hepatitis)
Differential Diagnoses
- Bacteremia
- Dengue
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Leptospirosis
- Malaria
- Meningitis, Aseptic
- Meningitis, Bacterial
- Meningococcal Infections
- Mononucleosis and Epstein-Barr Virus Infection
- Rickettsial Infection
- Viral Hemorrhagic Fevers
Gardner CL, Ryman KD. Yellow fever: a reemerging threat. Clin Lab Med. Mar 2010;30(1):237-60. [Medline].
Ellis BR, Barrett AD. The enigma of yellow fever in East Africa. Rev Med Virol. Sep-Oct 2008;18(5):331-46. [Medline].
McFarland JM, Baddour LM, Nelson JE, et al. Imported yellow fever in a United States citizen. Clin Infect Dis. Nov 1997;25(5):1143-7. [Medline].
Centers for Disease Control and Prevention. Fatal yellow fever in a traveler returning from Venezuela, 1999. MMWR Morb Mortal Wkly Rep. Apr 14 2000;49(14):303-5. [Medline].
Centers for Disease Control and Prevention. Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. MMWR Morb Mortal Wkly Rep. Apr 19 2002;51(15):324-5. [Medline].
Barnett ED. Yellow fever: epidemiology and prevention. Clin Infect Dis. Mar 15 2007;44(6):850-6. [Medline].
Staples JE, Gershman M, Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. Jul 30 2010;59:1-27. [Medline].
Khromava AY, Eidex RB, Weld LH, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine. May 9 2005;23(25):3256-63. [Medline].
Sibailly TS, Wiktor SZ, Tsai TF, et al. Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. Dec 1997;16(12):1177-9. [Medline].
Goujon C, Tohr M, Feuille V. Good tolerance and efficacy of yellow fever vaccine among subjects who are carriers of human immunodeficiency virus. In: Abstracts, 4th International Conference on Travel Medicine. 1995.
Nasidi A, Monath TP, Vandenberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg. May-Jun 1993;87(3):337-9. [Medline].
Nishioka Sde A, Nunes-Araujo FR, Pires WP, et al. Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study. Trop Med Int Health. Jan 1998;3(1):29-33. [Medline].

